Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

62.58

-0.86 (-1.36%)

At close: Jan 16, 2026, 4:00 PM EST

63.33

+0.75 (1.20%)

After-hours: Jan 16, 2026, 6:04 PM EST

Cytokinetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	7,651	5,551	8,186	4,336	3,823	1,471	Upgrade
Market Cap Growth	37.83%	-32.19%	88.80%	13.41%	159.96%	134.31%	Upgrade
Enterprise Value	8,039	5,448	8,396	4,210	3,612	1,201	Upgrade
Last Close Price	62.58	47.04	83.49	45.82	45.58	20.78	Upgrade
PS Ratio	85.40	300.50	1087.18	45.84	54.29	26.35	Upgrade
PB Ratio	-	-41.01	-21.19	-40.18	15.68	12.97	Upgrade
P/TBV Ratio	-	-	-	-	15.68	12.97	Upgrade
P/OCF Ratio	-	-	-	-	-	164.46	Upgrade
EV/Sales Ratio	92.18	294.90	1115.03	44.50	51.29	21.51	Upgrade
Debt / Equity Ratio	-2.59	-6.82	-1.96	-6.95	1.11	1.23	Upgrade
Asset Turnover	0.06	0.02	0.01	0.10	0.10	0.14	Upgrade
Quick Ratio	6.78	6.08	6.00	9.25	7.35	15.10	Upgrade
Current Ratio	6.88	6.17	6.12	9.40	7.45	15.20	Upgrade
Return on Equity (ROE)	-	-	-	-572.15%	-120.54%	-248.50%	Upgrade
Return on Assets (ROA)	-24.93%	-30.11%	-33.73%	-21.83%	-16.94%	-14.26%	Upgrade
Return on Capital Employed (ROCE)	-44.30%	-43.90%	-68.80%	-34.90%	-24.20%	-18.70%	Upgrade
Earnings Yield	-9.83%	-10.62%	-6.43%	-8.97%	-5.63%	-8.65%	Upgrade
FCF Yield	-5.93%	-7.20%	-5.08%	-7.17%	-5.01%	-0.14%	Upgrade
Buyback Yield / Dilution	-11.00%	-16.01%	-7.46%	-16.83%	-19.16%	-12.07%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q